The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 12, 2016

Filed:

Nov. 06, 2009
Applicants:

Ebo D. DE Muinck, Hanover, NH (US);

Jose R. Conejo-garcia, East Thetford, VT (US);

Inventors:

Ebo D. de Muinck, Hanover, NH (US);

Jose R. Conejo-Garcia, East Thetford, VT (US);

Assignee:

Celdara Medical, LLC, Lebanon, NH (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 35/15 (2015.01); A61K 38/16 (2006.01); A61K 38/47 (2006.01);
U.S. Cl.
CPC ...
A61K 38/164 (2013.01); A61K 38/168 (2013.01); A61K 38/47 (2013.01);
Abstract

Compositions and methods useful for targeted depletion or modulation of dendritic cells are provided. The compositions and methods can be used to promote healing of ischemia-related injury, including ischemia-reperfusion injury. Disclosed are a variety of dendritic cell-targeted toxins, bone morphogenetic protein 7 (BMP7) agonists, and dendritic cell-targeted transforming growth factor beta 1 (TGF-β1) antagonists, all useful in practicing methods of the invention. The inventive compositions and methods can be used in the treatment of various conditions including myocardial infarction, stroke, and critical limb ischemia.


Find Patent Forward Citations

Loading…